Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bliss

Showing results (241-250 of 378) with videos related to

Pageof 38
Sort By:
Breast Cancer Research and Treatment|August 24, 2010
Reversal of skeletal effects of endocrine treatments in the Intergroup Exemestane StudyRobert E Coleman, Linda M Banks, Samia I Girgis, et al.
British Journal of Cancer|October 9, 1998
Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patientsM Shayeghi, S Seal, J Regan, et al.
Gastrointestinal Endoscopy|January 1, 2021
Quantification of gastric mucosal microcirculation as a surrogate marker of portal hypertension by spatially resolved subdiffuse reflectance spectroscopy in diagnosis of cirrhosis: a proof-of-concept studyArpan Mohanty, Adam Eshein, Phanisyam Kamineni, et al.
Breast Cancer Research and Treatment|January 26, 2019
Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIESZsolt Szijgyarto, Koen D Flach, Mark Opdam, et al.
Journal of Virology|December 3, 2020
The Fiber Knob Protein of Human Adenovirus Type 49 Mediates Highly Efficient and Promiscuous Infection of Cancer Cell Lines Using a Novel Cell Entry MechanismAlexander T Baker, James A Davies, Emily A Bates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2010
A randomised comparative trial of infusional ECisF versus conventional FEC as adjuvant chemotherapy in early breast cancer: the TRAFIC trialB Sirohi, R A'Hern, G Coombes, et al.
JCO Precision Oncology|September 11, 2020
Genomic Instability and <i>TP53</i> Genomic Alterations Associate With Poor Antiproliferative Response and Intrinsic Resistance to Aromatase Inhibitor TreatmentEugene F Schuster, Pascal Gellert, Corrinne V Segal, et al.
The Journal of Extra-Corporeal Technology|August 6, 1995
The buffering ability of commonly employed cardiopulmonary bypass solutions and alkalizing agentsR E Crawford, L M Bliss, M E Schneider, et al.
BJC Reports|August 18, 2025
Hidden costs and unmet supportive care needs among individuals with experience of breast cancer and their carers in the United KingdomSzeyi Ng, Lucy S Kilburn, Hilary Stobart, et al.
Hepatology (Baltimore, Md.)|August 11, 2019
Use of an Outbred Rat Hepacivirus Challenge Model for Design and Evaluation of Efficacy of Different Immunization Strategies for Hepatitis C VirusErwan Atcheson, Wenqin Li, Carly M Bliss, et al.
Pageof 38

Showing results (241-250 of 378) with videos related to

Sort By:
Pageof 38
Breast Cancer Research and Treatment|August 24, 2010
Reversal of skeletal effects of endocrine treatments in the Intergroup Exemestane StudyRobert E Coleman, Linda M Banks, Samia I Girgis, et al.
British Journal of Cancer|October 9, 1998
Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patientsM Shayeghi, S Seal, J Regan, et al.
Gastrointestinal Endoscopy|January 1, 2021
Quantification of gastric mucosal microcirculation as a surrogate marker of portal hypertension by spatially resolved subdiffuse reflectance spectroscopy in diagnosis of cirrhosis: a proof-of-concept studyArpan Mohanty, Adam Eshein, Phanisyam Kamineni, et al.
Breast Cancer Research and Treatment|January 26, 2019
Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)-PathIESZsolt Szijgyarto, Koen D Flach, Mark Opdam, et al.
Journal of Virology|December 3, 2020
The Fiber Knob Protein of Human Adenovirus Type 49 Mediates Highly Efficient and Promiscuous Infection of Cancer Cell Lines Using a Novel Cell Entry MechanismAlexander T Baker, James A Davies, Emily A Bates, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2010
A randomised comparative trial of infusional ECisF versus conventional FEC as adjuvant chemotherapy in early breast cancer: the TRAFIC trialB Sirohi, R A'Hern, G Coombes, et al.
JCO Precision Oncology|September 11, 2020
Genomic Instability and <i>TP53</i> Genomic Alterations Associate With Poor Antiproliferative Response and Intrinsic Resistance to Aromatase Inhibitor TreatmentEugene F Schuster, Pascal Gellert, Corrinne V Segal, et al.
The Journal of Extra-Corporeal Technology|August 6, 1995
The buffering ability of commonly employed cardiopulmonary bypass solutions and alkalizing agentsR E Crawford, L M Bliss, M E Schneider, et al.
BJC Reports|August 18, 2025
Hidden costs and unmet supportive care needs among individuals with experience of breast cancer and their carers in the United KingdomSzeyi Ng, Lucy S Kilburn, Hilary Stobart, et al.
Hepatology (Baltimore, Md.)|August 11, 2019
Use of an Outbred Rat Hepacivirus Challenge Model for Design and Evaluation of Efficacy of Different Immunization Strategies for Hepatitis C VirusErwan Atcheson, Wenqin Li, Carly M Bliss, et al.
Pageof 38